Among the clinical features evaluated in the present study that have been used as biomarkers for COVID-19, we could observe that ACE2 genetic variant had an impact on D-dimer, ferritin, lactate dehydrogenase, and CRP levels. This evidence concerns the gene ACE2 and COVID-19.